Literature DB >> 8665922

Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor.

F Atmani1, J Mizon, S R Khan.   

Abstract

Uronic-acid-rich protein (UAP) is a urinary glycoprotein that inhibits calcium oxalate crystallization in vitro. It shows a structural similarity to bikunin, a component of inter-alpha-inhibitor (IalphaI) known for its inhibition of the action of many serine proteinases like trypsin and chymotrypsin. To clarify the relationship between these macromolecules, UAP, IalphaI, urinary bikunin, and plasma bikunin were purified and studied. Their calcium oxalate crystallization inhibitory activity was assayed before and after treatment with chondroitinase AC and pronase. Their molecular mass was determined by using SDS/PAGE before and after these treatments. Polyclonal bikunin antibody was used on Western blots for immunological identification. The partial amino acid sequence of UAP before and after chondroitinase treatment was determined. Also, the antitryptic activity of UAP was measured and compared to that of bikunin, which is responsible for the antiprotease activity of IalphaI. UAP exhibited a strong calcium oxalate crystallization inhibitory activity. IalphaI and both bikunins were less inhibitory. Chondroitinase AC had no effect on inhibitory activity of these proteins even when their molecular mass changed. However, after pronase treatment, the inhibitory activity of both bikunins and UAP was completely destroyed. The antitryptic activity of UAP was found to be 0.78 U/mg which is lower than that of bikunin which is about 1.9 U/mg. On Western blotting, bikunin antibody immunoreacted with UAP and both urinary and plasma bikunins. Partial amino acid sequence confirmed the identity of UAP as urinary bikunin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665922     DOI: 10.1111/j.1432-1033.1996.00984.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Models for protein binding to calcium oxalate surfaces.

Authors:  Asiya Gul; Peter Rez
Journal:  Urol Res       Date:  2007-03-20

3.  Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.

Authors:  J A Wesson; V Ganne; A M Beshensky; J G Kleinman
Journal:  Urol Res       Date:  2005-04-28

4.  Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells.

Authors:  Jasjit S Grewal; Jeng Y Tsai; Saeed R Khan
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

Review 6.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11

7.  Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.

Authors:  Saeed R Khan; Sunil Joshi; Wei Wang; Ammon B Peck
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05

Review 8.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

9.  Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition.

Authors:  Sunil Joshi; Wei Wang; Saeed R Khan
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.